A NorthStar Healthcare REIT lawyer at Weltz Law represents investors who lost money in NorthStar Healthcare Income, a non-traded REIT sold by brokers at $10 per share or more. When the company was sold in 2025, stockholders received $3.03 per share. When a registered broker recommended the REIT, the dispute may belong in FINRA arbitration.
Our NorthStar Healthcare REIT lawyers work inside the FINRA dispute resolution forum on behalf of investors nationwide. FINRA stands for the Financial Industry Regulatory Authority. It oversees brokerage firms and runs the arbitration system for most disputes between investors and their brokers.
This page is part of our alternative investment attorney section, within our broader securities lawyer practice.
Our seasonsed attorneys have over 30 years of collective experience, and our committed to protecting investors rights. Call today or contact us through our site.
☎ Call NowNorthStar Healthcare Income, Inc. was a non-traded real estate investment trust, or REIT, that owned senior housing, skilled nursing, medical office, and other healthcare properties. It was formed in 2010 and sold shares to retail investors through brokerage firms across the country.
A REIT is a company that owns income-producing real estate and pays out most of its income to shareholders. A non-traded REIT does not trade on a stock exchange. That means investors cannot simply sell their shares when they want out.
NorthStar Healthcare raised about $2 billion from investors. Shares first sold at $10.00 and later at $10.20. Many buyers were retirees looking for steady income.
NorthStar Healthcare's share value fell sharply over time. Its estimated value dropped to $7.10 per share in late 2018, and distributions were suspended in early 2019. By mid-2024, the board set the value at $2.96 per share. The company was later sold for $3.03 per share.
Here is the rough timeline, based on public reports:
For an investor who paid $10.20 per share, $3.03 is a loss of about 70% before counting any distributions received along the way.
Brokers often pitched NorthStar Healthcare as a stable, income-paying real estate investment tied to an aging population. Many buyers were told about the regular distributions and the growing need for senior care. Fewer heard clearly about high fees, no exit, and the risk of losing principal.
The story sounded sensible. Baby boomers are aging. Senior housing demand should grow. A REIT that owns those buildings should do well.
But non-traded REITs carry costs and risks that the story leaves out. Upfront fees and commissions on many non-traded REITs have run around 10% or more of the purchase price. That money never goes into real estate.
Brokers also earned high commissions on these sales. That created an incentive to sell, even when the product did not fit the customer.
Brokers should have explained that NorthStar Healthcare shares could not be easily sold and that high upfront fees cut the money actually invested. They should also have said distributions were not guaranteed and the value could fall far below the purchase price.
Liquidity was the first problem. With no public market, investors could only sell through limited company buyback programs, if those were open at all.
Distributions were another. Some non-traded REITs pay distributions that exceed what their properties earn. That can mean paying investors with their own money or with borrowed funds.
Then there was concentration in one sector. Healthcare real estate faces its own risks, from operator troubles to changes in government payment programs. The COVID-19 pandemic hit senior housing especially hard.
Finally, the reported share value could lag behind reality. Investors may have kept seeing a value near what they paid long after the properties had lost ground.
The 2025 sale to a Welltower affiliate gave NorthStar Healthcare shareholders $3.03 per share in cash and ended the REIT as a separate company. For many investors, it turned a paper loss into a final, locked-in loss compared with what they paid.
The deal was announced in January 2025 at an enterprise value of about $900 million. The price was slightly above the board's $2.96 estimate from mid-2024. Stockholders voted to approve it in June 2025.
For years, some investors held on and hoped values would come back. The sale closed that door. What remains is the question of how the shares were sold in the first place.
Possibly. The merger does not by itself erase a claim against the broker or firm that sold the shares. A FINRA claim focuses on the original recommendation, not on what later happened to the company. Timing and the facts of the sale still control whether a claim may move forward.
Here's the part many investors miss. The broker's conduct happened at the time of sale. The merger simply set the final number.
Some investors also bought more shares later, through distribution reinvestment or added purchases. Those dates may matter when looking at the six-year window.
NorthStar Healthcare REIT investors may be able to bring a FINRA claim when a registered broker or brokerage firm recommended or sold the shares. The claim focuses on the broker's conduct. That can include an unsuitable recommendation, a misleading description of risk, or too much money in one REIT.
A falling share price alone does not create a claim. Real estate values move, and the pandemic hurt many healthcare properties. The question is what the broker and firm did, and what they told the investor.
Claims tied to NorthStar Healthcare losses may include unsuitable investment recommendations, misleading information, over-concentration, and failure to supervise. Our REIT lawyer page covers non-traded REIT claims more broadly.
Over-concentration means putting too much of an investor's money into one investment or one type of investment. Some brokers placed a large share of a client's savings in NorthStar Healthcare, or in several non-traded REITs at once. For those clients, the drop in value hit far harder.
Many states and brokerage firms set limits on how much of a client's net worth can go into non-traded REITs. Those limits exist because these products are risky and hard to sell.
Picture a retired teacher with $400,000 in savings. Her broker puts $150,000 into NorthStar Healthcare and two other non-traded REITs. When values fall and payments stop, more than a third of her nest egg is frozen and shrinking.
That kind of allocation raises hard questions about suitability. When older investors are involved, it may also raise concerns about financial elder abuse.
Brokerage firms are expected to review a non-traded REIT before offering it. That includes the sponsor's history, fees, debt, how distributions are funded, and the risks of the property sector. Firms must also make sure brokers follow concentration limits and suitability standards.
A firm's review should not stop at the sponsor's sales materials. It should test the numbers and ask hard questions about risk.
The suitability and best interest standards apply to every recommendation. Learn more about investment product due diligence and common types of REIT fraud.
The FINRA eligibility rule generally bars claims filed more than six years after the event that caused the dispute. For NorthStar Healthcare, that is often the purchase date. Many shares were bought years ago, so some claims may already fall outside the window.
This is a real hurdle for many NorthStar Healthcare investors. The offering ran years before the 2025 sale.
Still, the exact dates matter. State deadlines may also apply. Our NorthStar Healthcare REIT lawyers review purchase dates and account history early in any review.
A FINRA panel may consider the money an investor lost, what that money might have earned in suitable investments, interest, and costs. The panel decides which measures fit the facts. No one can say in advance what a panel will award.
Out-of-pocket damages compare what the investor paid with what came back, including distributions and the $3.03 merger payment. Well-managed account damages ask what the money would have earned in investments that matched the investor's goals.
The broker's statements, the firm's due diligence, and the size of the investment all shape the arguments our FINRA arbitration attorneys can make.
Gather your purchase confirmations, subscription agreement, the prospectus, account statements, distribution records, and every communication with your broker. Also keep any merger paperwork from the 2025 sale. These records show what you paid, what you received, and how the REIT was described.
The subscription agreement matters a great deal. It often lists the net worth, income, and goals the broker recorded for you. Those details may not match your real situation.
Emails, texts, and marketing pieces can show whether the REIT was pitched as safe income. If something is missing, the brokerage firm keeps its own records, and many can be requested during discovery.
Our NorthStar Healthcare REIT lawyers start with the purchase. When did you buy, who recommended it, what were you told, and how much of your savings went in? Those answers shape whether a FINRA claim fits and which claims to bring.
Next, our team compares the investment with your age, goals, income needs, and other holdings. The review also checks whether concentration limits were followed.
If the facts support a claim, our FINRA arbitration attorneys draft and file the Statement of Claim. That is the written filing that starts a FINRA case.
Discovery follows. Our team asks for the firm's due diligence files on the REIT, its product approval records, and the broker's commission data.
If the case reaches a final hearing, our NorthStar Healthcare REIT lawyers present the evidence and witnesses to the panel. No one can predict how a panel will rule. Our page on FINRA arbitration explains each stage.
Did a broker sell you NorthStar Healthcare Income shares as a safe income investment? It may be worth a closer look. A conversation with a NorthStar Healthcare REIT lawyer can help you understand what options may exist in FINRA arbitration. That includes whether timing still allows a claim.
Our NorthStar Healthcare REIT lawyers represent investors, retirees, families, and trusts nationwide. Bring your purchase records, statements, and merger paperwork if you have them. Contact Weltz Law today to talk through what happened.
Our seasonsed attorneys have over 30 years of collective experience, and our committed to protecting investors rights. Call today or contact us through our site.
☎ Call NowFill out the form below or call 877-905-7671 to schedule your free consultation
By Appointment Only
9171 Wilshire Blvd #500
Beverly Hills, CA 90210
Attorney Advertising | Prior results do not guarantee a similar outcome. The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
